wegovy is tirzepatide F.D.A. Approves New Obesity Drug That Will Compete With Wegovy vs Mounjaro | Semaglutide

Bian L, Han G, Zhao CW, Garl PJ, Wang XJ

16 June 2019

H.MarchJ

Generally, semaglutide-induced pancreatitis may be underestimated because patients with diabetes often present other risk factors, such as obesity, and are treated with other medications that may increase the risk of pancreatitis (Dagher et al., 2024)

Weight loss : Retatrutide showed 28.7% at 68 weeks (Phase 3 TRIUMPH-4) versus survodutide's 18.7% at 46 weeks (Phase 2), though cross-trial comparisons are inherently limited

These programs can significantly reduce the monthly cost of eligible medications, making them a better option for people without coverage or whose insurance doesnt cover weight loss treatment